Zepbound dosing schedule from the label: the 2.5 mg start, 2.5 mg step-ups, and the 5, 10 and 15 mg maintenance doses. Not medical advice.
Key points
- 01The 2.5 mg starting dose is an introductory dose. The Zepbound (tirzepatide) prescribing information describes 2.5 mg injected subcutaneously once weekly for the first four weeks. The label frames it as a starting dose meant to let the body adjust, and it is not one of the maintenance doses. People who read the first four weeks as treatment often conclude the medication is not working, when the label never claimed it would be at that step.
- 02Step up to 5 mg after four weeks. After the four introductory weeks, the label increases the dose to 5 mg once weekly. That is the first of the maintenance doses, and it is where a number of people stay. Nothing in the schedule requires you to keep climbing once tolerability and response are where your prescriber wants them.
- 03Further increases run in 2.5 mg steps. The label allows the dose to be increased in 2.5 mg increments after at least four weeks on the current dose. Four weeks is a floor, not a target, and a clinician can hold you on a step for longer. The intermediate strengths, 7.5 mg and 12.5 mg, exist precisely so that a step can be halved when the jump is not tolerated.
- 04The maintenance doses are 5, 10 and 15 mg. For weight reduction the label names 5 mg, 10 mg or 15 mg once weekly as the recommended maintenance doses. The 7.5 mg and 12.5 mg strengths are transitional rungs on the way up rather than end points, although in practice a prescriber may keep someone on one if it is working and tolerated.
- 0515 mg once weekly is the ceiling in the label. The prescribing information names 15 mg once weekly as the maximum recommended dosage. There is no approved step above it, and going higher is not a decision a patient can make from the pen, because each pen is fixed at a single strength and there is no way to dial more.
- 06The sleep apnoea indication has its own maintenance doses. Zepbound is also approved to treat moderate to severe obstructive sleep apnoea in adults with obesity, and for that indication the label names 10 mg or 15 mg once weekly as the maintenance dosage. The escalation to get there is the same 2.5 mg start with 2.5 mg steps, so the early weeks look identical.
- 07One pen is one strength and one whole dose. The Zepbound single-dose pen is fixed at the strength printed on it and delivers the entire weekly dose in one activation. There is no dose dial and nothing to count. When your prescriber moves you up a step, you receive a new prescription for pens of the new strength, and the old strength is not adjustable to reach it.
- 08The vial presentation carries the same strengths. Zepbound is also supplied as single-dose vials at 2.5, 5, 7.5, 10, 12.5 and 15 mg per 0.5 mL. The schedule is identical, but the procedure is not, since a vial needs a separate sterile syringe and needle each time. Our guide to injecting Zepbound from a single-dose vial walks through that draw-up.
- 09Same day each week, with or without food. The injection is once weekly on the same day, and the label does not tie it to meals or to a time of day. Picking a day that is reliably calm matters more than picking a clever one. Our post on the best time of day to inject explains why the consistency, not the clock, is the part that changes outcomes.
- 10Moving your injection day has one rule. The day of the week can be changed when it needs to be, provided the interval between two doses is at least three days, which is 72 hours. That is the number to plan a shifted trip or a busy weekend around, and it is why a time-zone move rarely disrupts a weekly medication in practice.
- 11A missed dose has a four-day window. The prescribing information describes taking a missed dose as soon as possible within four days, which is 96 hours. If more than four days have passed, the label directs you to skip it and take the next dose on the regularly scheduled day. Doubling up to compensate is not in the label at any point.
- 12Only your prescriber changes a step. Whether to move up, hold, or step back down is a clinical decision that weighs side effects, weight response and other medications. Skipping a rung to move faster is the single most common self-modification, and it is the one the four-week interval exists to prevent. Bring data to that conversation rather than a request.
- 13What the supplies do at each step. The needle, the site rotation and the sharps routine do not change as the milligrams go up, and the storage numbers do not either, since the label allows up to 21 days at no more than 30 C at every strength. The only thing that changes at a step-up is the box, which is why the lot number belongs in your injection record.
- 14Why four weeks and not two. The interval is not arbitrary. It gives gastrointestinal side effects time to settle at the current strength before the next increase is layered on top, and it gives a clinician a clean four-week window of data to judge. A shorter interval blurs the two, so a side effect that would have faded on its own gets read as intolerance.
- 15Stepping back down is part of the schedule too. If a step is not tolerated, returning to the previous strength is a normal move rather than a failure, and the label supports the prescriber deciding the pace in both directions. What is not supported is doing it yourself, since it means the pens in your fridge no longer match your plan.
- 16The pens are strength-coded, so read the box every week. During a titration you may have two strengths in the house at once, the one you are finishing and the one you are moving to. The cartons look similar and the difference is a number. Checking the strength against your record before every injection is a thirty-second habit that prevents a real dosing error.
- 17What the schedule does not tell you about supply. A step-up means a new prescription, a new pharmacy fill and sometimes a new prior authorisation. People who wait until the last pen is used discover that the paperwork takes longer than the pen does. Start the conversation a week before the current strength runs out.
- 18The schedule interacts with everything else you inject. If you also take insulin or another glucose-lowering medication, a step-up can change how those behave, and the label expects the prescriber to consider it. Bring the full list to the appointment rather than only the tirzepatide, and see our guide to injecting with other medications.
- 19Track the ramp on paper, not in your head. Four-week blocks are surprisingly hard to reconstruct from memory once a holiday or an illness has shifted a dose. A written record of the date you started each strength turns the question of when am I due to step up into a two-second check instead of a guess.
Common mistakes
- Severe upper abdominal pain that may radiate to the back, with or without vomiting, which can indicate pancreatitis.
- A lump or swelling in the neck, hoarseness or trouble swallowing. Tirzepatide carries a boxed warning for thyroid C-cell tumours.
- Swelling of the face, lips, tongue or throat, or difficulty breathing, which can indicate a serious allergic reaction. Seek emergency care.
- Vomiting or diarrhoea severe enough that you cannot keep fluids down, which raises the risk of dehydration and kidney problems.
- Severe pain in the upper right abdomen with fever, nausea or yellowing of the skin, which can indicate gallbladder disease.
- Shakiness, sweating or confusion, which can indicate low blood sugar and is more likely alongside insulin or a sulfonylurea.
Frequently asked questions
What is the Zepbound dosing schedule?+
The label describes 2.5 mg once weekly for four weeks, then 5 mg once weekly. Further increases follow in 2.5 mg steps after at least four weeks on the current dose, up to a maximum of 15 mg weekly. Your prescriber decides each step. Educational information only, not medical advice.
Why does Zepbound start at 2.5 mg?+
The prescribing information describes 2.5 mg as a starting dose that lets the body adjust to the medication. It is not counted among the maintenance doses, so the first four weeks are an on-ramp rather than a trial of whether the medication works for you.
What are the Zepbound maintenance doses?+
For weight reduction the label names 5, 10 and 15 mg once weekly. For obstructive sleep apnoea it names 10 or 15 mg once weekly. The 7.5 mg and 12.5 mg strengths sit between the maintenance doses as intermediate steps.
Can I stay on 5 mg?+
The label lists 5 mg as a maintenance dose, so staying there is a recognised outcome rather than an incomplete titration. Whether it is right for you is a question for the person who prescribed it, and tolerability is a legitimate reason to hold.
How long between Zepbound doses if I change my injection day?+
The label allows the day of weekly administration to be changed as long as at least three days, meaning 72 hours, separate two doses. Keep the record of the actual dates rather than relying on memory across a shifted week.
What if I miss a Zepbound dose?+
The prescribing information describes taking it as soon as possible within four days, which is 96 hours. Beyond that, skip the dose and inject the next one on the usual day. Never double a dose to catch up. Our missed-dose guide covers the reasoning.
Does the dose schedule change if I use vials instead of pens?+
No. The strengths and the escalation are the same. What changes is the procedure, because a single-dose vial needs a fresh sterile syringe and needle for each dose rather than a self-contained pen.
Can I go back down a step?+
Stepping back to the previous strength when a dose is not tolerated is a normal clinical move, and the label leaves the pace to the prescriber in both directions. Do not do it on your own, because the pens you hold will no longer match the plan.
Why do I have two strengths in the house during a titration?+
Because a step-up arrives as a new prescription while the old pens are still in the fridge. Check the strength printed on the pen against your record before every injection, since the cartons look alike and the difference is one number.
When should I ask for the next prescription?+
About a week before the current strength runs out. A step-up can involve a new fill and sometimes new authorisation paperwork, and the paperwork is usually slower than the pen.
Sources
- Eli Lilly. Zepbound (tirzepatide) Prescribing Information (US label).
- Eli Lilly. Zepbound (tirzepatide) US Prescribing Information, PDF.
- DailyMed (NIH). Current prescribing information and instructions for use.
- Frid AH et al. 2016. New Insulin Delivery Recommendations. Mayo Clinic Proceedings 91(9):1231-1255.